Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada
The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Male or female ≥22 years and ≤ 60 years of age [+3]
Any known systemic cartilage and/or bone disorder, such as, but not limited to,... [+15]